-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-248-fullreport.pdf
December 01, 2019 - Depressive
symptoms can be both prolonged and episodic, recurring over weeks and months (National
Research … tracking of treatment goals and outcomes, including assessment of depressive symptoms and
functioning … Additionally, minority
adolescents may present depressive symptoms differently from non-Latino whites … The use of standardized tools is essential for tracking depressive symptoms and monitoring
patient response … Measuring and tracking depressive symptoms is important to improve patient outcomes (Knaup,
et al.,
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1406.pdf
June 01, 2014 - symptoms compared with patients receiving traditional in-
person therapy sessions. … symptoms and suicidal ideations within 40 minutes compared with
placebo. … symptoms were randomly assigned to complete SPARX or standard in-person behavioral
therapy. … Course of improvement in depressive
symptoms to a single intravenous infusion of
ketamine vs add-on … Rapid decrease in depressive symptoms with
an N-methyl-d-aspartate antagonist in ECT-
resistant major
-
hcup-us.ahrq.gov/reports/factsandfigures/figures/2006/2006_5_2a.jsp
January 01, 2006 - Depression
Distribution of Discharges with a Principal Diagnosis of Depression† and All Discharges … by Age Group,* 2006
AGE GROUP
PERCENT DISTRIBUTION
DEPRESSION
ALL DISCHARGES
Ages
-
hcup-us.ahrq.gov/reports/factsandfigures/figures/2006/2006_5_2d.jsp
January 01, 2006 - Depression
Discharge Prevalence for Depression by Region, 2006
REGION
DISCHARGES PER
-
hcup-us.ahrq.gov/reports/factsandfigures/figures/2006/2006_5_2b.jsp
January 01, 2006 - Depression
Percent of Depression Stays with Secondary Chronic Conditions or Secondary Mental … Health and Substance Abuse Diagnoses by Age, 2006
SEONDARY CONDITION TYPE
PERCENT OF DEPRESSION
-
hcup-us.ahrq.gov/reports/factsandfigures/figures/2006/2006_5_2c.jsp
January 01, 2006 - Depression
Discharge Prevalence for Depression by Median Income of Patient Zip Code, 2006
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1412.pdf
December 01, 2014 - symptoms compared with symptoms of patients receiving
traditional in-person therapy sessions. … symptoms and
suicidal ideations within 40 minutes compared with placebo. … , potentially restoring normal emotional processing and easing depressive symptoms.69
Clinical data … Course of improvement in depressive
symptoms to a single intravenous infusion of
ketamine vs add-on … Rapid decrease in depressive symptoms
with an N-methyl-d-aspartate antagonist in ECT-
resistant major
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1506.pdf
June 01, 2015 - For many patients, single ketamine doses often reduce depressive symptoms
within 2 hours, with improvements … symptoms within a few
hours or days, exponentially faster than many approved antidepressants.12,13 … symptoms and suicidal ideation within 40
minutes compared with placebo. … Course of improvement in depressive
symptoms to a single intravenous infusion of
ketamine vs add-on … Rapid decrease in depressive symptoms
with an N-methyl-d-aspartate antagonist in
ECT-resistant major
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1306.pdf
October 01, 2014 - believe that dysfunction in glutamate
neurotransmission may play a major role in the etiology of depressive … symptoms in both bipolar
disorder and MDD, although its exact mechanism of action is still unknown … symptoms
improved both significantly and rapidly and that these effects lasted from 3 days to several … Course of improvement in depressive
symptoms to a single intravenous infusion of
ketamine vs add-on … Rapid decrease in depressive symptoms
with an N-methyl-d-aspartate antagonist in ECT-
resistant major
-
effectivehealthcare.ahrq.gov/sites/default/files/05_depression_potential_high_impact_2012-12-10.pdf
January 01, 2012 - believe that dysfunction in glutamate neurotransmission may play a major
role in the etiology of depressive … symptoms in both bipolar disorder and MDD, although its exact
mechanism of action is still unknown … symptoms
improved both significantly and rapidly and that these effects lasted from 3 days to several … Course of improvement in depressive
symptoms to a single intravenous infusion of
ketamine vs add-on … Rapid decrease in depressive symptoms with
an N-methyl-d-aspartate antagonist in ECT-
resistant major
-
effectivehealthcare.ahrq.gov/sites/default/files/05_depression_potential_high_impact_june_2012.pdf
January 01, 2012 - believe that dysfunction in glutamate neurotransmission may play a major
role in the etiology of depressive … symptoms in both bipolar disorder and MDD, although its exact
mechanism of action is still unknown … symptoms improved both significantly and rapidly, and that these effects lasted from three days to … Course of improvement in depressive
symptoms to a single intravenous infusion of
ketamine vs add-on … Rapid decrease in depressive symptoms
with an N-methyl-d-aspartate antagonist in ECT-
resistant major
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1512.pdf
December 01, 2015 - and the severity of certain depressive
symptoms. … antidepressant, partly due to a
hypothesized link between dysfunctional glutamate neurotransmission and depressive … symptoms
observed in BPD and MDD.4
Preclinical studies indicate that ketamine’s antidepressant properties … Rapid decrease in depressive symptoms
with an N-methyl-d-aspartate antagonist in
ECT-resistant major … depression.
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1312.pdf
October 01, 2014 - Researchers believe that dysfunctional glutamate
neurotransmission may play a major role in causing depressive … symptoms in both BPD and MDD,
although its exact mechanism of action is still unknown.59,61 Studies … symptoms improved both significantly and rapidly and that these effects
lasted from 3 days to several … Course of improvement in depressive
symptoms to a single intravenous infusion of
ketamine vs add-on … Rapid decrease in depressive symptoms with
an N-methyl-d-aspartate antagonist in ECT-
resistant major
-
effectivehealthcare.ahrq.gov/sites/default/files/depression_hi_impact.pdf
October 01, 2014 - believe that dysfunction in glutamate neurotransmission could play a major role in the
etiology of depressive … symptoms, although its exact mechanism of action is still unknown.
24
Research
suggests that N-methyl-D-aspartate … , investigators concluded, “Within 40 minutes, depressive symptoms
significantly improved in subjects … Deep brain stimulation for
treatment-resistant depression. … depression.
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/depression/chipra-248-section-2.pdf
December 11, 2019 - Adolescent Depression Monitoring
Adolescent Depression Monitoring
Measure Description
Percentage … of patients 12 to 17 years of age who had a visit or other contact for major depression or
dysthymia … contact and a
diagnosis of major depression or dysthymia during the four month period
Exclusions … Denominator 2
Patients 12 to 17 years of age who have at least one depression-related contact
during … Denominator 3
Patients 12 to 17 years of age who have at least one depression-related contact
during
-
cds.ahrq.gov/taxonomy/term/41791
February 18, 2019 - Search All AHRQ Sites
Careers
Contact Us
Español
FAQs
Email Updates
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-brain-injury-surveillance-160902.pdf
January 30, 2014 - "
Depression"Scale"scores"(HADS)"(treatment"M=10.63"[2.67]h"waitlist"M=9.56"[3.09])"suggest"
that"participants"experienced"mildKtoKmoderate"depressive"symptoms … $symptoms$(CES"D$M=16$[mild$
depression]S$n=67)$found$a$significant$
reduction$in$depressive$symptoms … $and$anxiety$and$reducing$depressive$symptoms. … $symptoms$
(CES"D$M=16$[mild$
depression]S$n=67)$found$a$
significant$reduction$in$
depressive$symptoms … $Brain$morphometry$changes$and$
depressive$symptoms$after$traumatic$brain$injury.$Psychiatry!
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-247-fullreport.pdf
December 01, 2019 - Depressive symptoms can be both prolonged and episodic, recurring over weeks and months
(National Research … Additionally, minority
adolescents may present depressive symptoms differently than non-Latino whites … The use of standardized tools is essential for tracking depressive symptoms and monitoring
patient response … and regular tracking of
treatment goals and outcomes, including assessing depressive symptoms and function … Measuring and tracking depressive symptoms are important to improve patient outcomes
(Knaup, et al.,
-
www.ahrq.gov/topics/depression.html
Topic: Depression
Depression is a serious medical illness. … If you are one of the more than 19 million teens and adults in the United States who have depression, … AHRQ has research, tools and resources on depression and how clinicians can help their patients with … to Create Clinical Guidelines for Physicians
Efficacy and Safety of Screening for Postpartum Depression … Screening for Depression in Adults
-
psnet.ahrq.gov/issue/association-between-physician-depressive-symptoms-and-medical-errors-systematic-review-and
January 12, 2022 - Association Between Physician Depressive Symptoms and Medical Errors: A Systematic Review and Meta-analysis … symptoms found that physicians who screened positive for depression were associated with medical errors … longitudinal studies, which revealed there was a bidirectional association between physician symptoms of depression … This finding implies that physicians that screen positive for depressive symptoms have a higher risk … Association Between Physician Depressive Symptoms and Medical Errors: A Systematic Review and Meta-analysis